Background {#Sec1}
==========

MicroRNAs (miRNAs) are endogenous, non-coding RNAs with complex roles causing translational repression/degradation of bound mRNA \[[@CR1]\], regulating many cellular processes \[[@CR2]\]. They have intracellular effects, are extremely stable when secreted into the bloodstream \[[@CR3]\] and have been identified in multiple body fluids \[[@CR4]\]. MiRNAs are often tissue-specific and can be secreted from their tissue of origin into the bloodstream bound to lipoproteins \[[@CR5]\] or packaged into extracellular microparticles \[[@CR6]\]. When in blood they are termed circulating miRNAs (ci-miRNAs) \[[@CR7]\] and are emerging as potential diagnostic biomarkers due to their stability \[[@CR8]\] and ease of access for sample collection.

Human studies have identified a multitude of ci-miRNAs up-regulated following intense exercise training \[[@CR9]--[@CR12]\]. Furthermore, exercise training has been found to alter the expression pattern of miRNAs in skeletal muscle \[[@CR11], [@CR13], [@CR14]\]. It has been hypothesised that skeletal muscle may contribute to changes in differentially expressed (DE) ci-miRNAs in response to exercise training by releasing exosomes into plasma \[[@CR15], [@CR16]\], supporting the possibility that DE plasma ci-miRNAs could be used to assess adaptive training responses of skeletal muscle.

MiRNA analysis in horses is an emerging area of research. To-date, \>700 equine miRNAs have been identified with subsets of tissue-specific DE miRNAs isolated \[[@CR17]\] including skeletal muscle and blood \[[@CR18], [@CR19]\]. Recently, 197 miRNAs were identified in equine skeletal muscle, with 76 found to be muscle-specific \[[@CR20]\]. However, to-date there has only been one study evaluating ci-MRNA in exercising horses \[[@CR21]\]. In this report, 167 DE miRNAs were identified from pre- and post-endurance exercise blood samples; however, whole-blood rather than plasma/serum was evaluated making it difficult to determine if ci-miRNAs were expressed from red blood cells (RBC) or other tissue sites such as skeletal muscle.

There are technical challenges involved in plasma/serum ci-miRNA measurement such as inaccurately quantifying plasma RNA due to low yields, haemolysis impacting on ci-miRNA quantification and a lack of validated stable reference miRNAs \[[@CR22]--[@CR25]\]. Since haemolysis may occur naturally in horses following moderate-to-intense exercise \[[@CR26], [@CR27]\], this needs to be considered when attempting to evaluate equine plasma/serum ci-miRNA expression.

The aim was to identify DE plasma ci-miRNAs and skeletal muscle miRNAs before and after exercise in Thoroughbreds (Tb), and to evaluate for the presence and effect of haemolysis on plasma ci-miRNA determination.

Methods {#Sec2}
=======

A Department of Health License (B100/3525), ethical approval from the University College Dublin Animal Research Ethics Committee and owner consent were obtained for all horses and procedures in this study.

Sample population {#Sec3}
-----------------

All horses in the study were from the same stable and were managed and trained in a similar way \[[@CR28]\]. Horses trained 6 days per week with gradual introduction of 800--1000 m sprint training (work day \[WD\]) alternating with submaximal training, following which horses entered competitive racing.

Experimental protocol {#Sec4}
---------------------

### Cohort A: Plasma ci-miRNA {#Sec5}

Plasma lactate concentrations (\[LA\]) and ci-miRNA were evaluated in *n* = 20 sex- and fitness-matched 3 year-old Tbs (*n* = 10 males, *n* = 10 females) in active training and racing before (T~0~) and 5 mins after (T~5min~) a WD training session. The degree of haemolysis was evaluated in all samples.

### Cohort B: Skeletal muscle miRNA {#Sec6}

Resting (T~0~) and T~5min~ plasma \[LA\] along with T~0~ and 4 h (T~4hr~) post-exercise skeletal muscle miRNAs were evaluated in *n* = 11 2 year-old Tbs (*n* = 7 males, *n* = 4 females) before and after their first WD training session.

### Cohort C: Degree of plasma haemolysis {#Sec7}

The degree of haemolysis was further evaluated in T~0~ plasma samples from an additional *n* = 12 Tbs in active training and racing (*n* = 5 males, *n* = 7 females, 2--4 years old).

Data collection {#Sec8}
---------------

Prior to an exercise test horses were fitted with a heart rate (HR) telemetry system[1](#Fn1){ref-type="fn"} and GPS unit[2](#Fn2){ref-type="fn"} which recorded speed, HR and distance.

Resting jugular venous blood samples were collected before feeding and exercise. Samples for plasma \[LA\] and ci-miRNA measurement were placed into fluoride oxalate and ethylenediamine tetraacetic acid (EDTA) tubes, respectively. Once collected all blood tubes were immediately centrifuged with plasma separated. \[LA\] was measured on-site with an autoanalyser.[3](#Fn3){ref-type="fn"} Plasma for haemoglobin concentrations \[Hb\] and ci-miRNA analysis was stored at 4 °C until transported to be stored at -80 °C (within 6 h of collection) and analysed as a batch at a later date.

Blood samples for miRNA {#Sec9}
-----------------------

MiRNAs were extracted from plasma samples[4](#Fn4){ref-type="fn"} with 4 μL amounts then reversely transcribed in 20 μL reactions.[5](#Fn5){ref-type="fn"} Exogenous RNA spike-ins (UniSp2, UniSp4, UniSp5, cel-miR-39-3p) provided by the manufacturer of the human serum/plasma focus miRNA PCR panel kit were added during RNA extraction and analysed according to the manufacturer's instructions^5^.

Haemolysis analysis {#Sec10}
-------------------

The degree of haemolysis was assessed by quantifying plasma \[Hb\] using a UV/VIS spectrophotometer,[6](#Fn6){ref-type="fn"} measuring oxyhaemoglobin absorbance at k = 414 nm \[[@CR22]\]. A value of ≤0.2 absorption units (AU) was used as the threshold for acceptable haemolysis and accurate quantification of ci-miRNA detection \[[@CR22]\].

Skeletal muscle biopsy samples for miRNA {#Sec11}
----------------------------------------

Skeletal muscle biopsies were obtained from the *gluteus medius* using a 6 mm-diameter, modified Bergstrom biopsy needle[7](#Fn7){ref-type="fn"} according to previously described methods \[[@CR29]\]. Samples were preserved in RNAlater[8](#Fn8){ref-type="fn"} until further processing.

Total RNA was extracted from 50 to 100 mg of tissue using a protocol combining TRIzol reagent,[9](#Fn9){ref-type="fn"} DNase treatment[10](#Fn10){ref-type="fn"} and RNeasy.[11](#Fn11){ref-type="fn"} RNA was quantified using a Qubit fluorimeter with the Qubit RNA HS assay. RNA quality was assessed using the 18S/28S ratio and RNA integrity number on an Agilent Bioanalyzer with the RNA 6000 Nano Lab-Chip kit.[12](#Fn12){ref-type="fn"} RNA (2 μL\@5 ng/ul) was reversely transcribed in 10 μL reactions^5^. UniSp6 (exogenous RNA spike-in) was added during cDNA conversion.

Real-time quantitative polymerase chain reaction measurements {#Sec12}
-------------------------------------------------------------

cDNA was assayed in 10 μL PCR reactions^5^. All miRNAs were assayed once by RT-qPCR on the Exiqon Human Serum/Plasma Focus miRNA PCR panel I and II. Each panel consisted of a 96 well plate with 179 miRNAs of interest and 15 controls (inter-plate calibrators, negative and spike-in controls). Amplification was performed in an Applied Biosystems StepOnePlus™ Real-Time PCR System. Amplification curves were analysed using Applied Biosystems software to obtain raw PCR cycle threshold (*C* ~t~) values.

miRNA quantification {#Sec13}
--------------------

Quality control measures (inter-plate calibration, ommission of outliers, miRNAs with *C* ~t~ values \>34 from analysis) were carried out using GeneEx software. MiRNAs with \>80% missing data were removed from the analysis, with missing values replaced with the mean value for that miRNA. Results from muscle biopsies were normalised to the global mean.

Statistical analysis {#Sec14}
--------------------

A paired Student's *t*-test was used to compare T~0~ and T~5min~ plasma haemolysis and ci-miRNAs and T~0~ and T~4h~ muscle miRNA abundance~.~ A Shapiro-Wilk test was performed to confirm that the *C* ~t~ data was normally distributed and the Benjamini and Hochberg method used to correct for multiple testing. Pearson's rank correlation was used to evaluate correlation between T~0~ and T~5min~ ci-miRNA expression level and absorbance at 414 nm, and a paired Student's *t*-test used to assess the significance of that correlation. Significance was set at *P* ≤ 0.05.

Prediction and annotation of miRNA targets {#Sec15}
------------------------------------------

Prediction of potential target genes and pathway analysis was completed using the DIANA-mirPath software \[[@CR30]\] in the Diana Tools suite. The DIANA-microT-CDS algorithm was used to predict potential target genes for DE miRNAs; these were then utilised by miRPath for KEGG pathway analysis, enriched through analysis of all predicted targets. A 0.8 default setting was used as the MicroT prediction score threshold with species set to human since there was no equine option. Since there is a high conservation of miRNAs accross species suggesting the sharing of biological functions, it was believed that inferences could be made on the function of equine miRNAs based on their human homologues. Significance for over-represented KEGG pathways was set as *P* ≤ 0.05 following Benjamini and Hochberg correction for multiple testing.

Results {#Sec16}
=======

Quality control for miRNA quantification {#Sec17}
----------------------------------------

The miRNA data for 7/20 horses from cohort A failed quality control and were omitted from analysis. All samples from cohort B passed quality control.

Physiological exercise parameters {#Sec18}
---------------------------------

For all horses undertaking an exercise test in the study, the average V~peak~ was 16.9 ± 0.98 m/s (range 15.2--18.5), the average HR~peak~ 221.4 ± 7.1 bpm (range 209--232) and the average total exercise distance 1130.19 ± 145.1 m/s (range 876--1471). The average pre- and 5 mins post-exercise plasma \[LA\] were 0.46 ± 0.09 mmol/l (range 0.33--0.63) and 26.3 ± 3.68 mmol/l (range 19.2--32.1), respectively. There were no significant differences between males and females regarding any of the exercise and physiological measurements.

### Cohort A: Plasma ci-miRNA {#Sec19}

In the equine plasma samples, 29% (52/179) of the miRNAs on the human plasma panel were detected at both timepoints, all of which had increased expression (3.23 ± 1.5 fold mean increase, 1.1--10.3 range increase) at T~5min~ when compared to T~0~. However, absorbance \>0.2 AU at 414 nm were detected in 11/13 T~0~ and all T~5min~ plasma samples for horses in cohort A, with absorbance peaks significantly higher in the T~5min~ samples (*P* = 1.2^−05^; Fig. [1](#Fig1){ref-type="fig"}). The T~0~ absorbance ranged from 0.15--0.39 AU with an average of 0.25 ± 0.06 AU while the T~5min~ values ranged from 0.26--0.76 AU with an average of 0.46 ± 0.13 AU. The expression levels of 35 miRNAs were significantly correlated (*r* \> 0.55, *P* \< 0.05) with absorbance and thus haemolysis levels in both T~0~ and T~5min~ samples while 13 miRNA expression levels were only significantly correlated with haemolysis in T~0~ samples; 4 miRNAs were not correlated with haemolysis at either time point. Due to the high levels of haemolysis in the plasma samples and the strong positive correlation between haemolysis and miRNA abundance (Fig. [2](#Fig2){ref-type="fig"}), it was not possible to accurately quantify exercise-induced changes in plasma ci-miRNA expression in the present study. There were no significant differences between males and females regarding any of the haemolysis and ci-miRNA measurements.Fig. 1Box and whiskers plot depicting the degree of haemolysis based on absorbance at 414 nm for *n* = 13 equine plasma samples before and after exercise (cohort A) and from *n* = 12 equine plasma sampes from horses at rest (cohort C). A value of ≤0.2 absorption units was used as the threshold for acceptable haemolysis and accurate quantification of ci-miRNA detection. The red line indicates the threshold above which accurate quantification of ci-miRNA is not possible Fig. 2Heatmap showing the levels of 52 miRNAs relative to the degree of haemolysis from *n* = 13 equine plasma samples before and after exercise. MiRNA abundance is presented as *C* ~t~ values and degree of haemolysis is the absorbance at 414 nm for each plasma sample

### Cohort B: Skeletal muscle miRNA {#Sec20}

In the equine skeletal muscle biopsy samples, 55% (98/179) of the miRNAs on the human plasma panel were detected at both T~0~ and T~4h~. Following the Benjamini and Hochberg correction for multiple testing, 5 of these miRNAs were significantly DE at T~4h~ (*P* \< 0.05; Fig. [3](#Fig3){ref-type="fig"}). The greatest expression difference was detected in miRNA miR-21-5p which increased 0.92 ± 0.2 fold. The expression of the miR-30b-5p and miR-30e-5p family members increased 0.52 ± 0.1 and 0.64 ± 0.2 fold, respectively. Expression of let-7d-3p and let-7d-5p decreased 0.68 ± 0.1 and 0.44 ± 0.1 fold, respectively. Using the DIANA-microT-CDS algorithm a total of 1687 gene targets for these 5 miRNAs were identified. The largest number of gene targets were identified for the miR-30 family members. In total 1077 of the predicted targets were unique to these 2 miRNAs while only 3 gene targets were predicted for let-7d-3p. The most over-represented KEGG pathways for each miRNA based on a predicted target gene list are summarised in Table [1](#Tab1){ref-type="table"} \[[@CR31], [@CR32]\]. Pathways previously implicated in the equine exercise response were significantly enriched among predicted targets of the DE miRNAs (Table [2](#Tab2){ref-type="table"}). These included the Jak-STAT signaling, MAPK signaling, insulin signaling and mTOR signaling pathways and long-term potentiation.Fig. 3Real time qRT-PCR results for miRNAs differentially expressed in skeletal muscle before and following exercise from *n* = 11 Thoroughbred horses. The standard 2-ΔΔCT method was used to determine mean fold changes in gene expression. All *C*t values were normalised using the global normalisation function in the GeneEx software package. A Student's *t*-test was used to identify significant differences in mRNA abundance between time-points Table 1The most over-represented KEGG pathways for each miRNA based on a predicted target gene listmiRNAFold changeadjusted *P* value*n* genesTop KEGG pathway*P* valuehsa-let-7d-3p−0.680.0023NANAhsa-miR-21-5p0.920.002243Cytokine-cytokine receptor interaction2.48E-06hsa-let-7d-5p−0.440.022370ECM-receptor interaction9.22E-06hsa-miR-30b-5p0.520.0231113Ubiquitin mediated proteolysis4.76E-10hsa-miR-30e-5p0.640.0421153Ubiquitin mediated proteolysis2.92E-08 Table 2Pathways previously implicated in the equine exercise response that were significantly enriched among predicted targets of the differntially expressed miRNAsKEGG pathway*P* value*n* genes*n* miRNAsB cell receptor signalling pathway1.4637E-06164Ubiquitin mediated proteolysis1.4637E-06254Neurotrophin signalling pathway3.75787E-06224T cell receptor signalling pathway3.75787E-06204TGF-beta signalling pathway9.00943E-06154PI3K-Akt signalling pathway4.61509E-05434Long-term potentiation0.000171436134Regulation of actin cytoskeleton0.000171436284MAPK signalling pathway0.000293552344Jak-STAT signalling pathway0.000485158224Axon guidance0.000671812223Arrhythmogenic right ventricular cardiomyopathy0.000834821133Hepatitis B0.000838527214Transcriptional misregulation in cancer0.002038503264Hypertrophic cardiomyopathy0.002113538133Insulin signalling pathway0.002113538194Mucin type O-Glycan biosynthesis0.00211353863Prostate cancer0.0021797134mTOR signalling pathway0.002349162114Acute myeloid leukaemia0.00308660494Adherens junction0.004193219144

### Cohort C: Degree of plasma haemolysis {#Sec21}

The average absorbance at 414 nm for this cohort was 0.21 ± 0.09 AU, ranging from 0.10--0.41 AU (Fig. [1](#Fig1){ref-type="fig"}); 7/12 samples had absorbtion peaks \>0.2 AU. There was no significant difference in resting haemolysis levels between cohorts A and C, confirming that haemolysis at rest is prevelant in Tb racehorses in high-intensity exercise training.

Discussion {#Sec22}
==========

The stability and ease of access for collecting samples for ci-miRNA measurement make them attractive as potential diagnostic biomarkers. However, in order to investigate ci-miRNAs as diagnostic tools it is vital to identify normal patterns of expression for different scenarios including responses to exercise. Furthermore, rigourous quality control measures must be in place to ensure reliable results. One adverse situation identified to cause variation in plasma ci-miRNA measurement is RBC haemolysis resulting in leakage of miRNAs into the plasma \[[@CR22], [@CR23], [@CR33]\]. This is important to consider since there appears to be distinct miRNA profiles for the various cell types in blood \[[@CR22]\]. Keeping this in mind, the use of stringent quality controls and careful sample handling has resulted in the accurate quantification of resting and post-exercise plasma ci-miRNAs from human subjects \[[@CR12]\].

In the present study, haemolysis above the threshold for accurate quantification of ci-miRNAs was identified in the majority of the resting plasma samples as well as in all of the T~5min~ plasma samples. Intravascular haemolysis has been identified to occur in horses following racing \[[@CR26]\], exercise on the treadmill \[[@CR34]--[@CR36]\] and after work on the gallops \[[@CR27]\]. Exercise-induced haemolysis in horses primarily results from increased fragility of erythrocytes \[[@CR37], [@CR38]\], hypothesized to be due to the frequent accumulation of RBCs in the spleen \[[@CR35], [@CR37]\]. Changes in pH due to anaerobic exercise has also been associated with increased erythrocyte fragility \[[@CR38]\], which also occurs in human althletes following maximal exercise \[[@CR39]\]. It was interesting to note that in the present study even resting plasma samples had a degree of haemolysis above the threshold for accurate quantification of ci-miRNA detection \[[@CR22]\]. We hypothesised that since the horses were in active training for 6 days of the week, which is typical for a flat racehorse training establishment, this resulted in almost daily and consistent exercise-induced insult to the RBCs resulting in persistent levels of haemolysis. Thus, the degree of plasma haemolysis and subsequent effect on miRNA abundance is important to consider when investigating plasma ci-miRNA levels in horses that are in active exercise programmes, even when evaluating pre-exercise samples.

In the present study plasma samples were analysed spectrophotometrically to determine levels of free Hb, as this is an extremely simple and accurate method to determine the extent of plasma haemolysis \[[@CR22]\]. For the 48/52 miRNAs detected in plasma in the current study, miRNA abundance was significantly correlated with absorbance at one or both sampling time points supporting correlation between haemolysis and plasma ci-miRNA detection. Since measurement of ≥90% of the detected plasma ci-miRNAs in the current study was correlated with haemolysis, an accurate assessment of the changes in ci-miRNA abundance in response to exercise could not be made. It is believed, however, that this problem could be overcome through the quantification of exosomal ci-miRNAs (plasma miRNAs packaged in vesicles) rather than measurement of all plasma ci-miRNAs. This technique would exclude all unpackaged miRNAs which may have been leaked into the plasma from haemolysed erythrocytes.

Our research group previously demonstrated that mRNA in equine skeletal muscle responds to a single bout of exercise as well as exercise training \[[@CR31], [@CR32]\]. These results underpinned our interest in evaluating the effect that exercise may have on equine skeletal muscle miRNA expression. The initial profiling for equine skeletal muscle miRNA expression in the present study was carried out on horses just entering sprint training. This was based on results from previous studies in our laboratory in which Tb skeletal muscle was found to have the greatest transcriptional response to intense exercise at this training stage \[[@CR31]\]. The 4 h post-exercise sampling time was also chosen based on previous work performed by our research group where it was identified to be the time-point exhibiting the most transcriptional activity \[[@CR31]\]. These observations are in agreement with several human exercise studies \[[@CR40]--[@CR42]\].

In this study we observed changes in equine skeletal muscle miRNA abundance following exercise. All five of the DE miRNAs from skeletal muscle expressed at T~4~ in the present study had been identified amongst the 48 miRNAs detected from haemolysed plasma samples from horses in cohort A. Furthermore, all five are known equine miRNAs with miR-30e-5p previously reported to be expresesed in muscle in a tissue-specific manner \[[@CR20]\]. Of great interest is that these five DE miRNAs are amongst 167 DE miRNAs reported from pre- and 30 min post-endurance exercise whole-blood samples in a group of *n* = 14 pure-breed/half-breed Arabian horses \[[@CR21]\].

In the present study, two members of the let-7 family of miRNAs, let-7d-3p and let-7d-5p, and miR-21-5p had increased expression following exercise. The Let-7 family of miRNAs are involved in the regulation of glucose homeostasis and insulin sensitivity \[[@CR43]\], both key processes in energy metabolism during exercise. Mir-21 has been shown to be involved in the fibrogenic pathway and the progression of Duchenne muscular dystrophy \[[@CR44]\], so may play a role in muscle remodelling during exercise training.

Two members of the miR-30 family, miR-30b-5p and miR-30e-5p, had decreased expression post-exercise. The miR-30 family has been shown to be down-regulated in *mdx4cv* mice (models for Duchenne muscular dystrophy), with in vitro analysis indicating that miR-30 miRNAs are decreased following injury and are increased during myoblast differentiation \[[@CR45]\]. These findings suggest that these miRNAs may play an important role in skeletal muscle growth and repair \[[@CR45]\]. The decreased expression in response to exercise may be related to repair of exercise-induced muscle damage. The over-representation of miRNA gene targets in exercise-related KEGG pathways certainly suggests that miRNAs play a key role in the modulation of gene expression in response to exercise.

Conclusions {#Sec23}
===========

In conclusion, our results indicate even resting plasma from horses in high-intensity training may not be suitable for ci-miRNA quantification due to haemolysis, although it is possible this problem could be overcome through the quantification of exosomal ci-miRNAs. However, identification of DE miRNAs in skeletal muscle indicates that modification of miRNA expression may contribute to adaptive training responses in Tbs. It is likely that additional miRNAs are differentially regulated in response to exercise but were undetectable due to the use of a human plasma panel. Future studies using a global platform such as miRNA sequencing will be required to generate a comprehensive profile of miRNAs in equine skeletal muscle at rest and following exercise. The most powerful approach to such an investigation would be an analysis of the miRNA-Seq transcriptome.
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